Search research articles
Contact Us
Filters
Showing results (71-80 of 91) with videos related to
Page
of 10
Sort By:
The Lancet. Global Health
|
January 27, 2019
Disparities by province, age, and sex in site-specific cancer burden attributable to 23 potentially modifiable risk factors in China: a comparative risk assessment
Wanqing Chen, Changfa Xia, Rongshou Zheng, et al.
Translational Lung Cancer Research
|
September 12, 2022
Survival of 7,311 lung cancer patients by pathological stage and histological classification: a multicenter hospital-based study in China
Siyi He, He Li, Maomao Cao, et al.
Cancer
|
August 23, 2022
Assessment of the compliance, influencing factors, and yielding results of liver cancer screening in a high-risk population: A cross-sectional study
Maomao Cao, He Li, Dianqin Sun, et al.
JAMA Network Open
|
December 19, 2022
Long-term Incidence Rates of Esophageal Squamous Cell Carcinoma in Chinese Patients With Low-grade Intraepithelial Neoplasia and Association of Surveillance Endoscopy With Incidence
He Li, Hongliang Wu, Maomao Cao, et al.
Science China. Life Sciences
|
September 10, 2024
Can patients with mild non-neoplastic lesions diagnosed at baseline screening be safely exempt from surveillance: evidence from multicenter community-based cohorts
Siyi He, Zhiyi Zhang, Guohui Song, et al.
Chinese Medical Journal
|
April 1, 2026
Management and outcomes of patients with liver cancer in China and the United States
Mengyuan Xu, Qiushuo Geng, Tianhao Shan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 20, 2022
Risk-Adapted Starting Age for Personalized Colorectal Cancer Screening: Validated Evidence From National Population-Based Studies
Xuesi Dong, Zilin Luo, Zheng Wu, et al.
Future Oncology (London, England)
|
January 5, 2024
Multicenter phase II study of moderate low-dose radiotherapy in indolent non-Hodgkin lymphoma: CLCG-iNHL-01 protocol
Lin-Rui Gao, Xinyue Wang, Changfa Xia, et al.
Plos Medicine
|
February 22, 2024
Combining fecal immunochemical testing and questionnaire-based risk assessment in selecting participants for colonoscopy screening in the Chinese National Colorectal Cancer Screening Programs: A population-based cohort study
Xuesi Dong, Lingbin Du, Zilin Luo, et al.
Science Bulletin
|
January 21, 2026
Global, regional, and national burden of hepatocellular carcinoma and contribution of nine modifiable risk factors across 185 countries/territories in 2022
Ping Li, Zhan Ding, Yuqi Feng, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 91) with videos related to
Sort By:
Page
of 10
The Lancet. Global Health
|
January 27, 2019
Disparities by province, age, and sex in site-specific cancer burden attributable to 23 potentially modifiable risk factors in China: a comparative risk assessment
Wanqing Chen, Changfa Xia, Rongshou Zheng, et al.
Translational Lung Cancer Research
|
September 12, 2022
Survival of 7,311 lung cancer patients by pathological stage and histological classification: a multicenter hospital-based study in China
Siyi He, He Li, Maomao Cao, et al.
Cancer
|
August 23, 2022
Assessment of the compliance, influencing factors, and yielding results of liver cancer screening in a high-risk population: A cross-sectional study
Maomao Cao, He Li, Dianqin Sun, et al.
JAMA Network Open
|
December 19, 2022
Long-term Incidence Rates of Esophageal Squamous Cell Carcinoma in Chinese Patients With Low-grade Intraepithelial Neoplasia and Association of Surveillance Endoscopy With Incidence
He Li, Hongliang Wu, Maomao Cao, et al.
Science China. Life Sciences
|
September 10, 2024
Can patients with mild non-neoplastic lesions diagnosed at baseline screening be safely exempt from surveillance: evidence from multicenter community-based cohorts
Siyi He, Zhiyi Zhang, Guohui Song, et al.
Chinese Medical Journal
|
April 1, 2026
Management and outcomes of patients with liver cancer in China and the United States
Mengyuan Xu, Qiushuo Geng, Tianhao Shan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 20, 2022
Risk-Adapted Starting Age for Personalized Colorectal Cancer Screening: Validated Evidence From National Population-Based Studies
Xuesi Dong, Zilin Luo, Zheng Wu, et al.
Future Oncology (London, England)
|
January 5, 2024
Multicenter phase II study of moderate low-dose radiotherapy in indolent non-Hodgkin lymphoma: CLCG-iNHL-01 protocol
Lin-Rui Gao, Xinyue Wang, Changfa Xia, et al.
Plos Medicine
|
February 22, 2024
Combining fecal immunochemical testing and questionnaire-based risk assessment in selecting participants for colonoscopy screening in the Chinese National Colorectal Cancer Screening Programs: A population-based cohort study
Xuesi Dong, Lingbin Du, Zilin Luo, et al.
Science Bulletin
|
January 21, 2026
Global, regional, and national burden of hepatocellular carcinoma and contribution of nine modifiable risk factors across 185 countries/territories in 2022
Ping Li, Zhan Ding, Yuqi Feng, et al.
Page
of 10